$35.42
-0.39-1.09%
At close: -
$35.42
0.000.00%
After Hours: Dec 20, 4:05 PM EDT
Agios Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Agios Pharmaceuticals using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-10-31 | $-1.43 | $1.11 | -228.8 % |
Jun 2024 | 2024-08-01 | $-1.69 | $-1.59 | -6.29 % |
Mar 2024 | 2024-05-02 | $-1.45 | $-1.65 | 12.1 % |
Dec 2023 | 2024-02-15 | $-1.72 | $-1.65 | -4.24 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-10-31 | $8.96M | $9.46M | -5.24 % |
Jun 2024 | 2024-08-01 | $8.62M | $9.75M | -11.6 % |
Mar 2024 | 2024-05-02 | $8.19M | $8.37M | -2.16 % |
Dec 2023 | 2024-02-15 | $7.10M | $7.94M | -10.5 % |
Agios Pharmaceuticals (AGIO) is scheduled to report earnings on February 13, 2025. The last reported earnings were for reported on October 31, 2024 for Q3.
The Actual EPS was $-1.43, which missed the estimate of $1.11.
The Actual Revenue was $9M, which missed the estimate of $9.5M.
Browse earnings estimates, EPS, and revenue on all stocks.